The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
T-cell infiltration in matched samples from malignant pleural mesothelioma (MPM) during evolution of disease.
 
Susana Cedres Perez
Consulting or Advisory Role - Amphera; Bristol-Myers Squibb; MSD Oncology
 
Garazi Serna
No Relationships to Disclose
 
Juan David Assaf Pastrana
No Relationships to Disclose
 
Patricia Iranzo
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Kyowa Kirin; Merck Sharp & Dohme; MSD Oncology; Roche
Travel, Accommodations, Expenses - Angelini Pharma; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer; Roche
 
Ana Callejo
Consulting or Advisory Role - Boehringer Ingelheim; Kyowa Hakko Kirin; Lilly; MSD Oncology; Roche Pharma AG; Sanofi
Travel, Accommodations, Expenses - Boehringer Ingelheim; Celgene; Kyowa Hakko Kirin; MSD Oncology; Pfizer; Roche Pharma AG
 
Nuria Pardo
No Relationships to Disclose
 
Alejandro Navarro
Consulting or Advisory Role - Boehringer Ingelheim; Bristol Myers Squibb Foundation; Pfizer
Speakers' Bureau - AstraZeneca Spain; Roche
Expert Testimony - Medsir; Oryzon Genomics
Travel, Accommodations, Expenses - Boehringer Ingelheim; Pfizer; Roche
 
Alex Martinez-Marti
Consulting or Advisory Role - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; MSD Oncology; Pfizer; Roche
Speakers' Bureau - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer; Roche
 
Carlos Cabrera Galvez
No Relationships to Disclose
 
Alberto Gonzalez-Medina
No Relationships to Disclose
 
Roberta Fasani
No Relationships to Disclose
 
Xavier Guardia
No Relationships to Disclose
 
Javier Gonzalo
No Relationships to Disclose
 
Caterina Carbonell
No Relationships to Disclose
 
Joan Frigola
No Relationships to Disclose
 
Ramon Amat
No Relationships to Disclose
 
Ana Vivancos
Stock and Other Ownership Interests - Reveal Genomics
Consulting or Advisory Role - Bayer (Inst); Bristol-Myers Squibb (Inst); Guardant Health (Inst); Incyte (Inst); Merck (Inst); Roche (Inst)
Research Funding - Bristol Meyers Squibb (Inst); Incyte (Inst); Roche (Inst)
 
Paolo Nuciforo
Honoraria - Bayer; MSD Oncology; Novartis
Consulting or Advisory Role - Bayer; MSD Oncology
Travel, Accommodations, Expenses - Novartis
 
Enriqueta Felip
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol Myers Squibb; Daiichi Sankyo Europe GmbH; GlaxoSmithKline; Janssen; Lilly; Merck Serono; MSD Oncology; Novartis; Peptomyc; Pfizer; Roche; Sanofi; Takeda
Speakers' Bureau - AstraZeneca; Bristol Myers Squibb; CME outfitters; Lilly; Medscape; Merck Sharp & Dohme; PeerVoice; Pfizer; Roche; Takeda
Research Funding - Merck (Inst); Merck KGaA (Inst)
Other Relationship - GRÍFOLS